Skin cancer is the most common cancer in the U.S., with over 5 million cases diagnosed each year. Early detection is key to successful treatment, but many delay screenings due to limited access or time. DermaSensor’s AI technology makes skin cancer detection faster and more accessible for everyone.
At PT Family Medicine, we’re proud to provide primary care, preventative care, and specialized sports medicine in Pennsylvania. We help patients reach their health goals with personalized, high-quality care. Using tools like DermaSensor, we detect skin irregularities early to support better health. Contact us today to schedule your appointment and take charge of your wellness.
Keep reading to learn how DermaSensor’s cutting-edge AI technology is transforming the approach to early skin cancer detection.
Overview of DermaSensor Technology
DermaSensor is a revolutionary medical device designed for rapid, non-invasive skin exams. It simplifies early assessment of skin conditions by scanning skin spots and skin lesions with harmless light waves to collect data from the skin underneath. Using advanced AI, it analyzes abnormal cells and the way cells form, providing instant screening test results. This helps primary care physicians and patients detect issues like squamous cell carcinoma or other forms of skin cancer quickly.
With DermaSensor, you can monitor your skin regularly and detect precancerous skin growths or even cancer cells early, ensuring timely treatment options. For more severe cases, treatments like liquid nitrogen may be advised to remove abnormal growths.
Common Skin Cancers
Not all skin cancers are the same—they are mainly grouped into basal cell carcinoma, squamous cell skin cancers, and malignant melanoma. Basal cell carcinoma, the most common, often appears as a pearly or waxy bump, developing in sun-exposed areas. Squamous cell cancers may look like a scaly patch or sore that won’t heal, also forming in sun-damaged skin.
Malignant melanoma, though less common, is the deadliest, developing as an irregular shape or dark spot, particularly on existing moles. Early detection of these abnormal cells is critical, as skin cancer treatment is most effective when cancers are treated early.
How AI Aids in Skin Cancer Detection
Artificial intelligence plays a key role in early skin cancer detection by identifying subtle patterns in abnormal cells that may not be visible during a traditional skin exam. AI systems analyze large datasets of skin growths and existing moles, offering screening test results with incredible precision. Devices like DermaSensor can even detect additional skin cancers or precancerous skin growths while sparing surrounding healthy skin.
With this technology, primary care physicians can identify increased risk, diagnose deep layers of affected skin cells, and provide faster cancer treatment—all without relying solely on a dermatologist annually. Clinical trial studies show AI-enabled tools match or exceed traditional diagnostic methods, improving outcomes and reducing invasive procedures like skin biopsy.
Benefits of Rapid, Non-Invasive Screening
- DermaSensor provides rapid results in seconds, streamlining the skin self-exam process.
- Its painless, non-invasive approach eliminates the discomfort of a traditional skin biopsy.
- Reduces patient anxiety by delivering quick screening test results and eliminating long wait times.
- Helps spot new skin growths, remaining cancer cells, or even blistering sunburns that could lead to additional skin cancers.
- Enhances efficiency for primary care physicians by integrating easily into workflows.
- Supports better patient care by facilitating quicker diagnoses and treatment options.
- Especially valuable for screening diverse skin tones, including darker skin tones where changes may be harder to spot.
Diagnose Skin Cancer and Early Detection
The importance of early detection cannot be overstated—skin cancers, especially squamous cell cancers, and malignant melanoma can spread to nearby lymph nodes or deep layers of the skin if untreated. The DermaSensor device empowers providers to deliver critical evaluations in underserved areas, such as those with limited access to dermatologists or organ transplant patients who face an increased risk of developing skin cancer due to weakened immune systems.
By incorporating DermaSensor into routine care, primary care physicians can identify abnormal cells on the top layer of the skin or surrounding healthy skin, and even detect skin spots affected by ultraviolet light (UV rays). This digital health tool has proven to identify cancers in areas like the genital area or hard-to-see regions during a skin self-exam. For example, in one clinic, DermaSensor detected early-stage squamous cell skin cancers and malignant melanoma that would have been missed during visual screening.
The Skin Cancer Foundation and the American Cancer Society emphasize the importance of screening tests and regular exams for skin conditions. Whether monitoring irregular shapes, new growths, or changes in existing moles, DermaSensor helps primary care physicians ensure earlier diagnoses, fewer invasive procedures, and better outcomes for patients. It’s not just a device—it’s a groundbreaking solution to improve skin health and save lives.
Transform Your Skin Health Starting Today
The DermaSensor device is transforming skin cancer detection by making early screenings accessible and effective, even in primary care settings. With earlier diagnoses and improved patient outcomes, it’s a crucial step forward in skin cancer care.
At PT Family Medicine, we’re committed to your health and wellness. Don’t wait—schedule an appointment with us today and take advantage of our skin cancer screening services powered by DermaSensor technology. Prioritize your skin health and ensure peace of mind. Contact us now!
